Literature DB >> 31598807

Relegating Psychosis: Blood Work and "Routine Connection" in the Clozapine Clinic.

Julia E H Brown1.   

Abstract

This paper attends to the sociality available in the clozapine clinic regimen and suggests that the social dimensions of clozapine treatment may be as important as the biochemical efficacy of clozapine. The clozapine clinic is where people diagnosed with chronic schizophrenia who take the antipsychotic clozapine go for routine monitoring of clozapine side effects, particularly haematological effects. Psychopharmaceutical treatments are often criticized for being reductionistic and dehumanizing, but clozapine clinics offer increased clinical contact in the age of deinstitutionalization. The inadvertent social benefits of biomedically reductive treatments have not previously been ethnographically attended to in the clozapine-only context. Drawing on 18 months of ethnographic fieldwork with 43 clozapine clients and 16 clinical caregivers in two clozapine clinics in the United Kingdom in Australia, I argue that routine clinical attachments in the clozapine clinic can serve a therapeutic role in terms of providing opportunities for clients' health agency, social competence and accountability. This socio-therapeutic quality appeared to be available because the clinical emphasis was not on psychotic illness. It depended, however, on reliable and familiar social exchanges inside the clinic and on the predictability of clinical activity. The importance of unemotional but unfailing relationships and rhythms in the clozapine clinic context echoes cross-cultural findings about how schizophrenia is managed more productively in environments that invite more neutral and equal social exchanges.

Entities:  

Keywords:  Clozapine treatment; Health agency; Moral agency; Schizophrenia; Social defeat

Mesh:

Substances:

Year:  2020        PMID: 31598807     DOI: 10.1007/s11013-019-09653-6

Source DB:  PubMed          Journal:  Cult Med Psychiatry        ISSN: 0165-005X


  15 in total

1.  Introduction to the special section: the anthropology of psychopharmaceuticals: cultural and pharmacological efficacies in context.

Authors:  Allison V Schlosser; Kristi Ninnemann
Journal:  Cult Med Psychiatry       Date:  2012-03

2.  Social defeat and the culture of chronicity: or, why schizophrenia does so well over there and so badly here.

Authors:  T M Luhrmann
Journal:  Cult Med Psychiatry       Date:  2007-06

3.  Futility in the practice of community psychiatry.

Authors:  Paul Brodwin
Journal:  Med Anthropol Q       Date:  2011-06

Review 4.  A review of clozapine safety.

Authors:  Joanna Fitzsimons; Michael Berk; Timothy Lambert; Michel Bourin; Seetal Dodd
Journal:  Expert Opin Drug Saf       Date:  2005-07       Impact factor: 4.250

5.  A Case Study of Clozapine and Cognition: Friend or Foe?

Authors:  George Savulich; Gisela Mezquida; Samuel Atkinson; Miguel Bernardo; Emilio Fernandez-Egea
Journal:  J Clin Psychopharmacol       Date:  2018-04       Impact factor: 3.153

6.  Actively Negotiating the Mind-Body Divide: How Clozapine-Treated Schizophrenia Patients Make Health for Themselves.

Authors:  Julia E H Brown; Simone Dennis
Journal:  Cult Med Psychiatry       Date:  2017-09

7.  The (un)managed self: paradoxical forms of agency in self-management of bipolar disorder.

Authors:  Talia Weiner
Journal:  Cult Med Psychiatry       Date:  2011-12

Review 8.  Schizophrenia and migration: a meta-analysis and review.

Authors:  Elizabeth Cantor-Graae; Jean-Paul Selten
Journal:  Am J Psychiatry       Date:  2005-01       Impact factor: 18.112

9.  Clinical writing and the documentary construction of schizophrenia.

Authors:  R J Barrett
Journal:  Cult Med Psychiatry       Date:  1988-09

10.  "No One Ever Even Asked Me that Before": Autobiographical Power, Social Defeat, and Recovery among African Americans with Lived Experiences of Psychosis.

Authors:  Neely Anne Laurenzo Myers; Tali Ziv
Journal:  Med Anthropol Q       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.